# US 2013/0252265 A1 · Method for testing for cerebral infarction via cartilage acidic protein 1

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0252265 A1
- Document ID: US20130252265A1
- Status: Published application
- Kind: A1
- Application number: 13/895,919
- Filed: 2013-05-16
- Published: 2013-09-26
- Earliest claimed: 2010-11-16
- Assignees: Mitsubishi Chemical Corporation; Hisayama Research Institute for Lifestyle Diseases; Kyushu University, National University Corporation
- Applicants: Mitsubishi Chemical Corporation
- Inventors: Takanari KITAZONO; Masahiro KAMOUCHI; Tetsurou AGOU; Takahiro KUWASHIRO; Yutaka KIYOHARA; Jun HATA; Hideto AWANO; Teruaki KOBAYASHI
- Web page: https://patentgrep.com/patent/US20130252265A1

## CPC

- G01N 33/6887: {from muscle, cartilage or connective tissue}
- G01N 2800/2871: Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A test method for diagnosing cerebral infarction, a test method for diagnosing the disease type of cerebral infarction, and a test method for predicting prognosis of cerebral infarction in a subject animal, which test methods comprise the step of measuring the amount of cartilage acidic protein 1 in a blood sample collected from the animal.

## Claims

### Claim 1

A test method for diagnosing cerebral infarction in a subject animal, comprising the step of measuring the amount of cartilage acidic protein 1 in a blood sample collected from said animal, wherein, in cases where the amount of said protein is lower than the amount in a healthy individual, said animal is judged to be cerebral infarction.

### Claim 2 (depends on 1)

The test method for diagnosing cerebral infarction according to claim 1, wherein said blood sample collected from said subject animal is a blood sample collected from said subject animal at any period between immediately after onset and 20 days after onset of cerebral infarction-like symptoms.

### Claim 3

A test method for predicting prognosis of cerebral infarction in a subject animal, said method comprising the step of measuring the amount of cartilage acidic protein 1 in a blood sample collected from said animal.

### Claim 4 (depends on 3)

The test method for predicting prognosis of cerebral infarction according to claim 3, wherein said blood sample collected from said subject animal is a blood sample collected from said subject animal 7 days after onset of cerebral infarction.

### Claim 5

A kit for testing for cerebral infarction, for evaluating a therapeutic effect on cerebral infarction, or for screening a candidate compound for a prophylactic/therapeutic drug for cerebral infarction, said kit comprising a reagent which enables measurement of the amount of cartilage acidic protein 1.
